state-of-the-art rADIATION TECHNOLOGY

Radiation therapy is often used alone or may be given in combination with other treatment modalities. Under the direction of a radiation oncologist, a physicist and dosimetrist use sophisticated treatment planning computers to precisely locate the cancer and meticulously compute a safe, optimal treatment dose. This state-of-the-art technology, administered by radiation therapists, consistently delivers radiation treatments enabling maximum response with minimal side effects.

The use of a High Dose Rate Remote Afterloader enables patients to receive a safe, yet aggressive therapy usually available only at university-affiliated treatment centers. The High Dose Rate Remote Afterloader provides the most direct form of radiation therapy available to patients with certain esophageal, prostate, gynecologic, skin, lung and brain cancers.


The Trilogy system is the world’s first non-invasive, image-guided radiation therapy system optimized for both conventional and stereotactic approaches to treating tumors and lesions. RapidArc™ technology represents the latest evolution of cancer treatment technology, setting new benchmarks for speed, precision and patient comfort.

Trilogy can deliver radiotherapy to treat volumes of cancer after surgery or as primary treatment for advanced disease. Highly contoured beams spare normal tissue. With Trilogy, even the smallest tumors can be treated—even as small as a pencil point—while minimizing damage to healthy tissue. It also delivers radiation faster than conventional linear accelerators, resulting in shorter treatment times and making the experience more comfortable for the patient. [READ MORE]


With the ability to deliver a non-invasive but highly accurate therapeutic dose of radiation to the brain with Gamma Knife, Archbold Memorial Hospital has transformed treatment for patients across the region with brain disorders and cancer metastases (cancer that has traveled to the brain from elsewhere in the body) for the last 12 years.

Using this state-of-the-art radiosurgery equipment, the Gamma Knife team has successfully treated over 900 patients since the hospital acquired the equipment through the generosity of Archbold Foundation donors in 2003.

The Gamma Knife Perfexion™, a technology that has been referred to as the “gold standard” treatment for radiosurgery of the brain. Archbold is one of only 275 hospitals worldwide to acquire Gamma Knife. And Archbold is the only hospital in the region with Gamma Knife Perfexion™ technology—the latest and most precise radiosurgery technology to hit the market. [READ MORE]


Internal radiation—also known as brachytherapy—is a type of radiation therapy in which radioactive material sealed in needles, seeds, wires or catheters is placed directly into or near a tumor. Depending on the type of implant a patient receives, the radiation source may stay in place for minutes, hours or days. Or if a patient receives a permanent implant, it will not be taken out.

Different forms of brachytherapy have served for many years as effective treatment of cancers such as skin, cervical, breast and prostate. Mesh brachytherapy, the newest form of targeted radiation delivered via the robotic surgical approach, offers promising treatment options for patients with any type of tumor in close margin to the chest or abdomen, historically considered to be inoperable areas.

Archbold general and thoracic surgeon Edward Hall, MD, and radiation oncologist Steven Johnson, MD, of Archbold’s Lewis Hall Singletary Oncology Center performed Georgia’s first implant of Cesium-131 mesh brachytherapy in an early stage lung cancer patient using the daVinci Surgical System in 2011, and have offered the treatment to qualifying patients ever since. Archbold was recognized as the first in the state, and second worldwide, to revolutionize surgical treatment for lung cancer using mesh brachytherapy and the daVinci Robot.This innovative technique offers a less radical surgical treatment for a large group of patients with lung cancer, who until receently had limited hope of finding a cure for their disease.

While minimally invasive surgery provides significant advantages over ‘open’ surgery, the advantages are even greater when lung surgery is performed using daVinci robotics. Robotic surgery is a viable surgical option that offers treatment to patients who otherwise would be left without feasible treatment options. DaVinci’s high definition 3D vision system provides a highly accurate, increased level of depth perception. The dexterity of the robotic arms enables us to perform complex surgical maneuvers easier. In many cases, by using daVinci, it’s possible to actually remove tumors in patients who otherwise would’ve been denied surgical treatment.

Unlike conventional lung surgeries, surgery with daVinci requires very little muscle to be cut and the rib cage does not need to be spread. In addition, patients experience many minimally invasive surgical advantages such as reduced length of stay in the hospital, less pain and quicker recoveries. Since the surgeon is already doing a surgical procedure to remove the tumor, targeted radiation done at the time of surgery is preferred. Application of thr radioactive mesh treats the ‘at risk tissue’ directly while maximally sparing normal tissue. It also eliminates many weeks of treatment that is required with traditional external radiation.